|
Dr. Huang is a graduate of the East China University of Science and Technology.
He received his B.Sc. and M.Sc. in 1984 and 1987 respectively. He
was conferred Ph.D. at the National University of Singapore in 1995
for his research in Chemical Engineering.
Dr Huang has extensive biotech experience in Germany
having spent two years at the German Biotechnology Center (GBF)
specialising in high cell density fermentation and process monitoring
and control. Between 1995 and 2001, he was also Associate Director
for the Ohio Bioprocessing Research Consortium responsible for business
development and process product development. Between 2001 and 2004,
he was the Chief Technology Director of Hong Kong 19. Pharmaceutical
(HKP), a publicly listed company. He took up the present post of
CTO at BCT in late 2005 and is responsible for the technology development
of BCT-100 as well as pre-clinical studies as per SFDA IND requirements
leading to the submission of US FDA IND. |
